Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Monitor measures early signs of pulmonary oedema:

This article was originally published in Clinica

Executive Summary

Israeli company RS Medical Monitoring has developed a device to monitor patients for early signs of pulmonary oedema, a potentially fatal complication associated with acute heart disease. The monitor, which measures changes in the active resistance in the lungs caused by an accumulation of fluids, gives an audio-visual signal if the fluid level exceeds or falls below pre-set levels.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT086651

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel